Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$521M |
| 2 |
Nike
NKE
|
+$509M |
| 3 |
Micron Technology
MU
|
+$439M |
| 4 |
Super Micro Computer
SMCI
|
+$435M |
| 5 |
Broadcom
AVGO
|
+$329M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$5.31B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.89B |
| 3 |
Amazon
AMZN
|
+$1.48B |
| 4 |
Microsoft
MSFT
|
+$1.07B |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 93% |
| 2 | Technology | 2.38% |
| 3 | Consumer Discretionary | 1.03% |
| 4 | Financials | 0.75% |
| 5 | Healthcare | 0.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11226
Unisys
UIS
$192M
| $65.8K | ﹤0.01% |
15,923
+4,248
| +36% | +$20.8K |
|
|
KLRS
11227
CALL
Kalaris Therapeutics
KLRS
$95.7M
| $65.6K | ﹤0.01% |
3,961
-9,865
| -71% | -$174K |
|
11228
PUT
BRC Inc
BRCC
$123M
| $65.6K | ﹤0.01% |
1,070
-60
| -5% | -$3.12K |
|
11229
Aterian
ATER
$7.61M
| $65.6K | ﹤0.01% |
+23,333
| New | +$58K |
|
11230
Myomo
MYO
$64.6M
| $65.3K | ﹤0.01% |
+20,343
| New | +$69K |
|
11231
CALL
FingerMotion
FNGR
$10.7M
| $65.3K | ﹤0.01% |
25,600
-22,300
| -47% | -$67.8K |
|
11232
CALL
Mammoth Energy Services
TUSK
$153M
| $65.3K | ﹤0.01% |
19,900
-71,900
| -78% | -$247K |
|
11233
MaxCyte
MXCT
$134M
| $65.2K | ﹤0.01% |
16,632
-22,680
| -58% | -$97.6K |
|
|
HERZ
11234
Herzfeld Credit Income Fund
HERZ
$32.1M
| $65.2K | ﹤0.01% |
2,773
+815
| +42% | +$19K |
|
11235
Kingstone Companies
KINS
$287M
| $65K | ﹤0.01% |
+13,002
| New | +$59.3K |
|
|
ICD
11236
DELISTED
Independence Contract Drilling, Inc.
ICD
| $65K | ﹤0.01% |
49,976
+5,494
| +12% | +$8.99K |
|
11237
CALL
Purple Innovation
PRPL
$20.8M
| $64.8K | ﹤0.01% |
2,492
+1,800
| +260% | +$63.3K |
|
|
XNET
11238
Xunlei
XNET
$321M
| $64.7K | ﹤0.01% |
38,528
-39,877
| -51% | -$66.6K |
|
11239
PUT
Vivani Medical
VANI
$127M
| $64.6K | ﹤0.01% |
51,300
-43,300
| -46% | -$74.2K |
|
|
CEI
11240
DELISTED
Camber Energy, Inc
CEI
| $64.6K | ﹤0.01% |
549,755
+221,818
| +68% | +$37.1K |
|
|
11241
PUT
FingerMotion
FNGR
$10.7M
| $64.5K | ﹤0.01% |
25,300
+14,200
| +128% | +$43.2K |
|
11242
Expensify
EXFY
$233M
| $64.3K | ﹤0.01% |
43,147
+28,099
| +187% | +$44.3K |
|
11243
CALL
Acacia Research
ACTG
$436M
| $64.1K | ﹤0.01% |
12,800
-41,500
| -76% | -$215K |
|
|
WPRT
11244
CALL
Westport Fuel Systems
WPRT
$35.3M
| $64.1K | ﹤0.01% |
11,500
-6,800
| -37% | -$40.1K |
|
|
AP.WS
11245
DELISTED
Ampco-Pittsburgh Corp Series A Warrants
AP.WS
| $63.8K | ﹤0.01% |
1,276,666
| – | – |
|
|
LILM
11246
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
| $63.7K | ﹤0.01% |
80,142
-55,956
| -41% | -$52.5K |
|
11247
CALL
DocGo
DCGO
$41.2M
| $63.7K | ﹤0.01% |
20,600
-117,700
| -85% | -$388K |
|
11248
CALL
Fossil Group
FOSL
$321M
| $63.6K | ﹤0.01% |
+44,200
| New | +$50.2K |
|
11249
AmeriServ Financial
ASRV
$85.6M
| $63.3K | ﹤0.01% |
28,025
-7,357
| -21% | -$18.3K |
|
11250
Cytosorbents Corp
CTSO
$22.7M
| $63.1K | ﹤0.01% |
89,788
+73,590
| +454% | +$63.8K |
|
Similar funds
Jeff Yass's Q2 2024 Portfolio in Review
As of Q2 2024, Jeff Yass held 13,638 positions worth $537B, down 6.7% from $576B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass's Q2 2024 filing shows 1,591 new, 4,593 increased, 5,607 reduced and 1,726 closed positions. Its largest new stake was NextEra Energy 7.299% Corporate Units: 2,575,000 shares worth $127M. The largest sale was NVIDIA, an estimated $5.31B.
By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q2 2024 buy was NextEra Energy 7.299% Corporate Units: 2,575,000 shares worth $127M.
- Jeff Yass added most to Vanguard FTSE Developed Markets ETF in Q2 2024, an estimated $521M increase.
- Jeff Yass's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $5.31B.
- Jeff Yass fully exited iShares MSCI USA Quality Factor ETF in Q2 2024, selling an estimated $26.2M.
- Jeff Yass's ten largest holdings make up 26% of its $537B portfolio in Q2 2024.
- Jeff Yass opened 1,591 new positions and closed 1,726 in Q2 2024.
- Jeff Yass's portfolio value fell 6.7% quarter-over-quarter to $537B.
Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.